Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Cardiol Clin. 2016 Aug;34(3):451–472. doi: 10.1016/j.ccl.2016.04.005

Figure 17.

Figure 17

Survival according to extent of pulmonary hypertension therapy in 275 recently diagnosed consecutive pediatric PAH patients at 3 referral centers between 2000 and 2010. Survival improves on combination therapy for pulmonary hypertension over monotherapy. CCB, calcium channel blocker.

From Zijlstra WM, Douwes JM, Rosenzweig EB. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies. J Am Coll Cardiol 2014;63(20):2159–69; with permission.